Aliases & Classifications for Measles

Summaries for Measles

MedlinePlus : 41 measles is an infectious disease caused by a virus. it spreads easily from person to person. it causes a blotchy red rash. the rash often starts on the head and moves down the body. other symptoms include fever cough runny nose conjunctivitis (pink eye) feeling achy and run down tiny white spots inside the mouth sometimes measles can lead to serious problems. there is no treatment for measles, but the measles-mumps-rubella (mmr) vaccine can prevent it. "german measles", also known as rubella, is a completely different illness. centers for disease control and prevention

MalaCards based summary : Measles, also known as rubeola, is related to bronchiolitis and erythema infectiosum, and has symptoms including exanthema, fever and pruritus. An important gene associated with Measles is CD46 (CD46 Molecule), and among its related pathways/superpathways are Innate Immune System and TGF-Beta Pathway. The drugs Vitamin A and BCG vaccine have been mentioned in the context of this disorder. Affiliated tissues include eye, brain and skin, and related phenotypes are hematopoietic system and cellular

Disease Ontology : 12 A viral infectious disease that results_in infection located in skin, has material basis in Measles virus, which is transmitted_by contact with oronasal secretions, or semen of an infected person. The infection has symptom fever, has symptom cough, has symptom coryza, has symptom conjunctivitis, and has symptom maculopapular, erythematous rash.

CDC : 3 Measles starts with fever, runny nose, cough, red eyes, and sore throat. It’s followed by a rash that spreads over the body. Measles virus is highly contagious virus and spreads through the air through coughing and sneezing. Make sure you and your child are protected with measles, mumps, and rubella (MMR) vaccine.

Wikipedia : 72 Measles is a highly contagious infection caused by the measles virus. Initial signs and symptoms... more...

Related Diseases for Measles

Diseases related to Measles via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 292)
id Related Disease Score Top Affiliating Genes
1 bronchiolitis 30.1 DDX58 IFNA1 IFNB1
2 erythema infectiosum 29.2 IFNG IL2 IL4
3 hepatitis c virus 29.1 ADAR DDX58 EIF2AK2 IFIH1 IFNG
4 lymphoma 28.4 CD40LG IFNG IL2 IL4
5 malaria 27.3 CD40LG FCGR2B IFNG IL2 IL4 TLR2
6 rheumatoid arthritis 27.1 CD40LG IFNG IL2 IL4 TLR2
7 rubella 12.1
8 primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection 11.8
9 panencephalitis, subacute sclerosing 11.7
10 mumps 11.3
11 congenital rubella 11.2
12 acute disseminated encephalomyelitis 11.2
13 hyperinsulinism due to short chain 3-hydroxylacyl-coa dehydrogenase deficiency 10.7 IFNA1 IFNB1
14 x-linked intellectual disability-precocious puberty-obesity syndrome 10.7 DDX58 IFIH1
15 infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations 10.7
16 striatonigral degeneration, infantile 10.7
17 immunodeficiency 45 10.7
18 microcephaly 10.7
19 acute hemorrhagic leukoencephalitis 10.7
20 croup 10.7
21 immune-mediated encephalomyelitis 10.7
22 postinfectious encephalomyelitis 10.7
23 burning mouth syndrome 10.7 CD209 IFNB1
24 sirenomelia 10.6 DDX58 IFIH1
25 hunter macpherson syndrome 10.5 ADAR IFNG STAT1
26 myoclonic astatic epilepsy 10.5 IFNG IL4
27 neonatal meningitis 10.5 CD46 MSN TLR2
28 acute necrotizing encephalitis 10.5 IFNB1 IFNG STAT1
29 holoprosencephaly 7 10.5 EIF2AK2 IFNA1 STAT1
30 eye accommodation disease 10.4 IFNG IL4
31 spastic paraplegia 15, autosomal recessive 10.4 IFNA1 IFNB1 STAT1
32 vaginal mullerian papilloma 10.4 CD209 CD40LG EIF2AK2
33 erysipelas 10.4 CD40LG IFNA1
34 chorioretinitis 10.4 CD40LG IFNA1
35 hepadnavirus infection 10.3 CD209 CD40LG IFNG
36 secretory diarrhea 10.3 CD40LG DDX58 IFNB1
37 congenital nystagmus 10.3 ADAR DDX58 EIF2AK2 IFNA1
38 acute contagious conjunctivitis 10.3 IFNG IL4 TLR3
39 bacterial gastritis 10.3 IFNA1 IFNG STAT1
40 hereditary ataxia 10.3 DDX58 EIF2AK2 IFNA1 IFNAR2
41 spoan syndrome 10.3 CD40LG IFNB1 STAT1
42 trachoma 10.2 CD40LG STAT1 TLR3
43 lower urinary tract calculus 10.2 CD209 DDX58 TLR3
44 angiodysplasia of intestine 10.2 CD209 DDX58 IFNB1 STAT1 TLR3
45 ocular albinism 10.2 ADAR IFIH1 IFNA1
46 cutaneous fibrous histiocytoma 10.2 CD40LG DDX58 IFNG TLR3
47 bartonellosis 10.1 CD40LG IFNG TLR2
48 vulvar nodular hidradenoma 10.1 IFNG IL4 STAT1
49 schneiderian carcinoma 10.1 CD209 IFNG STAT1 TLR2
50 diphtheria 10.1

Graphical network of the top 20 diseases related to Measles:



Diseases related to Measles

Symptoms & Phenotypes for Measles

UMLS symptoms related to Measles:


exanthema, fever, pruritus, koplik spots

MGI Mouse Phenotypes related to Measles:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10.24 IFNAR2 IFNB1 IFNG IL2 IL4 SLAMF1
2 cellular MP:0005384 10.14 CD40LG DDX58 EIF2AK2 FCGR2B IFIH1 IFNG
3 homeostasis/metabolism MP:0005376 10.13 ADAR CD40LG DDX58 FCGR2B IFIH1 IFNAR2
4 immune system MP:0005387 10.13 ADAR CD40LG DDX58 EIF2AK2 FCGR2B IFIH1
5 liver/biliary system MP:0005370 9.81 ADAR DDX58 FCGR2B IFIH1 IFNG IL2
6 mortality/aging MP:0010768 9.77 ADAR CD40LG DDX58 EIF2AK2 FCGR2B IFIH1
7 neoplasm MP:0002006 9.28 IFNG IL2 STAT1 TLR2 TLR3 DDX58

Drugs & Therapeutics for Measles

Drugs for Measles (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 103)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Vitamin A Approved, Nutraceutical, Vet_approved Phase 4,Phase 3 11103-57-4, 68-26-8 445354
2
BCG vaccine Investigational Phase 4,Phase 2
3 Antibodies Phase 4,Phase 3,Phase 2,Phase 1
4 Immunoglobulins Phase 4,Phase 3,Phase 2,Phase 1
5 Vaccines Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
6 Antioxidants Phase 4,Phase 3
7 Micronutrients Phase 4,Phase 3
8 Protective Agents Phase 4,Phase 3
9 Retinol palmitate Phase 4,Phase 3
10 Trace Elements Phase 4,Phase 3
11 Vitamins Phase 4,Phase 3
12 Pharmaceutical Solutions Phase 4,Phase 3,Phase 2,Phase 1
13 Heptavalent Pneumococcal Conjugate Vaccine Phase 4,Phase 3,Phase 2
14 Immunosuppressive Agents Phase 4,Phase 2,Phase 1
15 Adjuvants, Immunologic Phase 4
16 Liver Extracts Phase 4,Phase 1
17 retinol Nutraceutical Phase 4,Phase 3
18
Pyrimethamine Approved, Vet_approved Phase 3,Phase 2,Phase 1 58-14-0 4993
19
Sulfadoxine Approved Phase 3,Phase 2,Phase 1 2447-57-6 17134
20
Sulfamethoxazole Approved Phase 3 723-46-6 5329
21
Trimethoprim Approved, Vet_approved Phase 3 738-70-5 5578
22
Aluminum hydroxide Approved Phase 3,Phase 2,Phase 1 21645-51-2
23
Dapsone Approved, Investigational Phase 2, Phase 3 80-08-0 2955
24
Mefloquine Approved Phase 2, Phase 3 53230-10-7 4046
25
Proguanil Approved Phase 2, Phase 3 500-92-5 4923
26
Amoxicillin Approved, Vet_approved Phase 3 26787-78-0 33613 2171
27
Tetracycline Approved, Vet_approved Phase 3,Phase 2 60-54-8 5353990
28
Iron Approved Phase 3 7439-89-6 23925
29
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3,Phase 2,Phase 1 59-30-3 6037
30
leucovorin Approved, Nutraceutical Phase 3,Phase 2,Phase 1 58-05-9 143 6006
31
Lactitol Investigational Phase 3,Phase 2 585-86-4 3871
32
Chlorproguanil Investigational Phase 2, Phase 3 537-21-3 151170 9571037
33 Anti-Infective Agents Phase 3,Phase 2,Phase 1
34 Antimalarials Phase 3,Phase 2,Phase 1
35 Antiparasitic Agents Phase 3,Phase 2,Phase 1
36 Antiprotozoal Agents Phase 3,Phase 2,Phase 1
37 Fanasil, pyrimethamine drug combination Phase 3,Phase 2,Phase 1
38 Folic Acid Antagonists Phase 3,Phase 2,Phase 1
39 Renal Agents Phase 3,Phase 2,Phase 1
40 Vitamin B Complex Phase 3,Phase 2,Phase 1
41 Anti-Bacterial Agents Phase 3,Phase 2
42 Antibiotics, Antitubercular Phase 3,Phase 2
43 Antitubercular Agents Phase 3
44 Cytochrome P-450 Enzyme Inhibitors Phase 3
45 Trimethoprim, Sulfamethoxazole Drug Combination Phase 3
46 Antimetabolites Phase 2, Phase 3
47 PENTA Phase 3,Phase 2
48 gamma-Globulins Phase 3,Phase 2
49 Immunoglobulins, Intravenous Phase 3,Phase 2
50 Rho(D) Immune Globulin Phase 3,Phase 2

Interventional clinical trials:

(show top 50) (show all 225)

id Name Status NCT ID Phase Drugs
1 Additional Measles Vaccine at 4 Months of Age Unknown status NCT01486355 Phase 4
2 Trial of Additional Measles Vaccine to Reduce Child Mortality Unknown status NCT01644721 Phase 4
3 Trial of Additional Measles Vaccine to Reduce Child Mortality. Burkina Faso. Unknown status NCT01668745 Phase 4
4 The Effect on Overall Mortality of a National Policy of Limiting Measles Vaccination to Children Below 12 Months of Age Unknown status NCT01306006 Phase 4
5 The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR Vaccine Unknown status NCT02153866 Phase 4
6 Vitamin A Supplementation With Routine Childhood Vaccines and Mortality and Morbidity Unknown status NCT00168623 Phase 4 Vitamin A
7 Vitamin A Supplementation With Bacille Calmette Guerin (BCG) Vaccine Unknown status NCT00168610 Phase 4 Vitamin A
8 Early Two-dose Measles Vaccination Trial Completed NCT00168558 Phase 4
9 Long-term Follow-up of Measles Antibodies Completed NCT00168571 Phase 4
10 Coadministration of Measles-rubella and Rotavirus Vaccines Completed NCT01700621 Phase 4
11 Non-Specific Effects of Standard Titre Measles Vaccination Completed NCT00168662 Phase 4
12 Immunogenicity of Co-administration of Measles and Japanese Encephalitis Vaccines Completed NCT02643433 Phase 4
13 Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases Completed NCT00126997 Phase 4
14 Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic Arthritis Completed NCT00731965 Phase 4
15 Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella Vaccine Completed NCT02880865 Phase 4
16 Study on Immunization Schedule of Beijing Tiantan Biological's Measles-mumps-rubella(MMR) Vaccine Completed NCT03160820 Phase 4
17 Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations Completed NCT01777529 Phase 4
18 Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine Completed NCT00313950 Phase 4
19 Measles, Mumps, and Rubella (MMR) Immunity in College Students Completed NCT00962819 Phase 4
20 MMR Vaccination Among HIV-infected Adults Completed NCT02724852 Phase 4
21 Immunology of Non-specific Effects of Vaccine Completed NCT00168545 Phase 4
22 Randomized Study of Not Giving Diphteria-tetanus-pertussis Vaccination With or After Measles Vaccination Completed NCT00244673 Phase 4
23 Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED) Completed NCT00326183 Phase 4
24 Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore. Completed NCT00388440 Phase 4
25 Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067) Completed NCT00312858 Phase 4
26 IPV Clinical Trial - The Gambia Completed NCT01847872 Phase 4 IPV IM Needle;IPV ID Needle;IPV IM Device;IPV ID Device
27 Immune Response to Rotavirus Vaccine After a Supplemental Dose Given at 9 Months of Age With Local EPI Vaccines in Mali Completed NCT02286895 Phase 4
28 Safety Study of a Refrigerator-stable Formulation of VARIVAX® Completed NCT00432731 Phase 4
29 Safety & Immunogenicity of MMR Vaccine by DSJI to That by Needle-Syringe in 15-18 Months Old Children Completed NCT02253407 Phase 4
30 MMR and Varicella Vaccine in Premature Infants Completed NCT00156559 Phase 4
31 Induction of Immunity Against Streptococcus Pneumoniae in Adults With Inflammatory Bowel Disease Completed NCT01908283 Phase 4
32 Different Doses of Vitamin A Supplementation and Male and Female Morbidity and Mortality Completed NCT00168636 Phase 4 Vitamin A
33 Study of the Influence of Vaccination in HIV Viral Load and Immunologic Responses Against HIV Completed NCT00329251 Phase 4
34 Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency Completed NCT00520494 Phase 4 Vivaglobin
35 Vitamin A With BCG Vaccine Completed NCT00168597 Phase 4 Vitamin A
36 Induction of Immunity Against Measles in Pediatric Liver Transplant Recipients Recruiting NCT01770119 Phase 4
37 Homeopathic Vaccine Trial Recruiting NCT02825368 Phase 4
38 Search for the Measles Vaccine Virus Excretion in Breast Milk of Breastfeeding Women After Postpartum Vaccination With MMR Active, not recruiting NCT02325310 Phase 4
39 The Phase IVd of Inactivated Enterovirus 71 Vaccine Enrolling by invitation NCT03296410 Phase 4
40 Measles-Rubella Vaccine Immunogenicity at 6 and 9 Months of Age Not yet recruiting NCT03071575 Phase 4
41 Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts Not yet recruiting NCT03183765 Phase 4 Measles-Mumps-Rubella Vaccine
42 Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines Terminated NCT00138255 Phase 4
43 Impact of the WHO Recommended Vitamin A Supplementation at Immunisation Contacts Terminated NCT00514891 Phase 4
44 Immunogenicity and Reactogenicity of a Trivalent MMR (Trivivac) in Healthy Infants Unknown status NCT01763268 Phase 2, Phase 3
45 The Community Effectiveness of IPTi in Southern Tanzania Unknown status NCT00152204 Phase 3 Sulfadoxine-pyrimethamine used for IPTi;IPTi
46 Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases Completed NCT00127010 Phase 3
47 Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases Completed NCT00127023 Phase 3
48 Prophylactic Antibiotics in Measles Completed NCT00168532 Phase 3 Sulfamethoxazole-Trimethoprim
49 Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older Completed NCT02058563 Phase 3
50 Determining Long-Term Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine Completed NCT00412516 Phase 3

Search NIH Clinical Center for Measles

Cochrane evidence based reviews: measles

Genetic Tests for Measles

Anatomical Context for Measles

MalaCards organs/tissues related to Measles:

39
Eye, Brain, Skin, T Cells, Lung, Testes, Liver

Publications for Measles

Articles related to Measles:

(show top 50) (show all 1422)
id Title Authors Year
1
Enhancing global vaccine pharmacovigilance: Proof-of-concept study on aseptic meningitis and immune thrombocytopenic purpura following measles-mumps containing vaccination. ( 28558983 )
2017
2
Comparison of cidofovir and the measles, mumps, and rubella vaccine in the treatment of recurrent respiratory papillomatosis. ( 28231366 )
2017
3
Genome-wide associations of CD46 and IFI44L genetic variants with neutralizing antibody response to measles vaccine. ( 28289848 )
2017
4
Risk factors for measles among adults in Tianjin, China: Who should be controls in a case-control study? ( 28950011 )
2017
5
Can Norway be kept free from rubella and measles? ( 28828847 )
2017
6
Heterogeneity in coverage for measles and varicella vaccination in toddlers - analysis of factors influencing parental acceptance. ( 28927384 )
2017
7
Soil transmitted helminth infections are not associated with compromised antibody responses to previously administered measles and tetanus vaccines among HIV-1 infected, ART naA^ve Kenyan adults. ( 28924616 )
2017
8
Does Measles Vaccination Reduce the Risk of Acute Respiratory Infection (ARI) and Diarrhea in Children: A Multi-Country Study? ( 28076428 )
2017
9
The utility of measles and rubella IgM serology in an elimination setting, Ontario, Canada, 2009-2014. ( 28850604 )
2017
10
Negative Correlation between Circulating CD4(+)FOXP3(+)CD127(-) Regulatory T Cells and Subsequent Antibody Responses to Infant Measles Vaccine but Not Diphtheria-Tetanus-Pertussis Vaccine Implies a Regulatory Role. ( 28855899 )
2017
11
Measles Lymphadenopathy in a Child With PFAPA Syndrome. ( 28882091 )
2017
12
Transitioning Lessons Learned and Assets of the Global Polio Eradication Initiative to Global and Regional Measles and Rubella Elimination. ( 28838195 )
2017
13
Mutations in the fusion protein of measles virus that confer resistance to the membrane fusion inhibitors carbobenzoxy-d-Phe-l-Phe-Gly and AS-48. ( 28904193 )
2017
14
Expansion of Surveillance for Vaccine-preventable Diseases: Building on the Global Polio Laboratory Network and the Global Measles and Rubella Laboratory Network Platforms. ( 28838191 )
2017
15
Positive predictive value and effectiveness of measles case-based surveillance in Uganda, 2012-2015. ( 28886171 )
2017
16
Pain caused by measles, mumps, and rubella vaccines: A systematic literature review. ( 28893478 )
2017
17
Complete Genome Sequences of Mumps and Measles Virus Isolates from Three States in the United States. ( 28818890 )
2017
18
A novel measles outbreak control strategy in the Netherlands in 2013-2014 using a national electronic immunization register: A study of early MMR uptake and its determinants. ( 28923422 )
2017
19
Measles Virus Enters Breast and Colon Cancer Cell Lines through a PVRL4-Mediated Macropinocytosis Pathway. ( 28250131 )
2017
20
Non-specific effects of measles, mumps, and rubella (MMR) vaccination in high income setting: population based cohort study in the Netherlands. ( 28855159 )
2017
21
Preliminary findings indicate nosocomial transmission and Roma population as most affected group in ongoing measles B3 genotype outbreak in Bulgaria, March to August 2017. ( 28920573 )
2017
22
The end of measles and congenital rubella: an achievable dream? ( 28067934 )
2017
23
Measles, Rubella and Varicella IgG Seroprevalence in a Large Refugee Cohort in Germany in 2015: A Cross-Sectional Study. ( 28875465 )
2017
24
Evaluation of Combination Measles-Mumps-Rubella-Varicella Vaccine Introduction in Australia. ( 28806450 )
2017
25
The damaged cortices and the uncontrolled Id: A case of post-measles hyper-sexuality. ( 28946115 )
2017
26
Timeliness of Measles Laboratory Reporting and Factors Associated with Delays, Zhejiang Province, China, 2009-2015. ( 28937792 )
2017
27
Documentation of Measles Elimination in Iran: Evidences from 2012 to 2014. ( 28878113 )
2017
28
Sporadic cases of adult measles: a research article. ( 28069071 )
2017
29
Knowledge, attitudes and opinions towards measles and the MMR vaccine across two NSW cohorts. ( 28898512 )
2017
30
Evolution of T Cell Responses during Measles Virus Infection and RNA Clearance. ( 28904342 )
2017
31
Modulation of the Type I Interferon Response Defines the Sensitivity of Human Melanoma Cells to Oncolytic Measles Virus. ( 28042780 )
2017
32
Mumps, Measles, and Rubella Vaccine for the Treatment of a Recalcitrant Subungual Wart. ( 28709617 )
2017
33
Utilization and impact of European immunization week to increase measles, mumps, rubella vaccine uptake in Austria in 2016. ( 28797728 )
2017
34
A large population-based association study between HLA and KIR genotypes and measles vaccine antibody responses. ( 28158231 )
2017
35
Decreasing Seroprevalence of Measles Antibodies after Vaccination - Possible Gap in Measles Protection in Adults in the Czech Republic. ( 28085960 )
2017
36
Impact of an Intervention to Use a Measles, Rubella, and Polio Mass Vaccination Campaign to Strengthen Routine Immunization Services in Nepal. ( 28838201 )
2017
37
The Measles Virus Receptor SLAMF1 Can Mediate Particle Endocytosis. ( 28100610 )
2017
38
Effect of an Early Dose of Measles Vaccine on Morbidity Between 18 Weeks and 9 Months of Age: A Randomized, Controlled Trial in Guinea-Bissau. ( 28931238 )
2017
39
Community-wide measles outbreak in the Region of Madrid, Spain, 10A years after the implementation of the Elimination Plan, 2011-2012. ( 28059628 )
2017
40
Cost Analysis of Measles in Refugees Arriving at Los Angeles International Airport from Malaysia. ( 28068211 )
2017
41
Measles burden in urban settings: characteristics of measles cases in Addis Ababa city administration, Ethiopia, 2004-2014. ( 28890752 )
2017
42
A Recombinant Measles Vaccine with Enhanced Resistance to Passive Immunity. ( 28934110 )
2017
43
The Conundrum in the Diagnosis and Management of Atypical Fulminant Measles in a Leukemia Survivor on Maintenance Chemotherapy. ( 27992394 )
2017
44
Efficacy of recombinant measles virus expressing highly pathogenic avian influenza virus (HPAIV) antigen against HPAIV infection in monkeys. ( 28931922 )
2017
45
Cost of a measles outbreak in a remote island economy: 2014 Federated States of Micronesia measles outbreak. ( 28886945 )
2017
46
"Screening Different Host Cell Lines for the Dynamic Production of Measles Virus". ( 28054473 )
2017
47
Pancreatic pseudocyst after measles, mumps, and rubella vaccination. ( 28082255 )
2017
48
Effect of an Early Dose of Measles Vaccine on Morbidity Between 18 Weeks and 9 Months of Age: A Randomized, Controlled Trial in Guinea-Bissau. ( 28077730 )
2017
49
Ongoing outbreak with well over 4,000 measles cases in Italy from January to end August 2017 - what is making elimination so difficult? ( 28933342 )
2017
50
Determinants of European parents' decision on the vaccination of their children against measles, mumps and rubella: A systematic review and meta-analysis. ( 27163657 )
2016

Variations for Measles

Expression for Measles

Search GEO for disease gene expression data for Measles.

Pathways for Measles

Pathways related to Measles according to GeneCards Suite gene sharing:

(show all 47)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.89 ADAR CD209 CD40LG CD46 DDX58 EIF2AK2
2
Show member pathways
13.54 EIF2AK2 IFNA1 IFNAR2 IFNB1 IFNG IL2
3
Show member pathways
13.35 ADAR CD40LG DDX58 EIF2AK2 IFNA1 IFNAR2
4
Show member pathways
13.22 FCGR2B IFNG IL2 IL4 STAT1 TLR2
5
Show member pathways
13.02 CD209 IFNA1 IFNAR2 IFNB1 STAT1 TLR2
6
Show member pathways
12.9 IFNA1 IFNAR2 IFNB1 IFNG IL2 STAT1
7
Show member pathways
12.88 CD40LG IFNA1 IFNG IL2 IL4 STAT1
8
Show member pathways
12.77 ADAR DDX58 IFIH1 IFNA1 IFNB1 IFNG
9
Show member pathways
12.7 CD40LG EIF2AK2 IL2 TLR2 TLR3
10 12.66 EIF2AK2 IFNA1 IFNAR2 IFNB1 IL2 IL4
11
Show member pathways
12.63 CD40LG IFNAR2 IFNG IL2 IL4
12
Show member pathways
12.6 IFNG IL2 IL4 STAT1 TLR2
13
Show member pathways
12.57 IFNA1 IFNAR2 IFNB1 IFNG IL2 IL4
14
Show member pathways
12.53 ADAR DDX58 EIF2AK2 IFNA1 IFNAR2 IFNB1
15
Show member pathways
12.41 CD40LG IFNG IL2 IL4
16
Show member pathways
12.35 IFNA1 IFNAR2 IFNB1 IFNG STAT1
17
Show member pathways
12.29 CD40LG IFNG IL4 STAT1 TLR2
18
Show member pathways
12.27 ADAR CD209 CD46 DDX58 EIF2AK2 FCGR2B
19 12.25 CD209 FCGR2B IFNA1 IFNB1 IFNG STAT1
20
Show member pathways
12.23 IFNB1 IFNG IL4 STAT1 TLR2
21 12.19 IFNG STAT1 TLR2 TLR3
22
Show member pathways
12.19 IFNA1 IFNAR2 IFNB1 IFNG IL2 IL4
23 12.19 CD40LG CD46 DDX58 IFIH1 IFNA1 IFNG
24 12.11 FCGR2B IFNAR2 IFNB1 IFNG STAT1
25
Show member pathways
12.06 IL2 STAT1 TLR2 TLR3
26 12.06 CD209 IFNG IL2 IL4 SLAMF1
27
Show member pathways
12.01 IFNG IL2 IL4 STAT1
28
Show member pathways
12.01 IFNG IL2 STAT1 TLR2 TLR3
29
Show member pathways
11.97 IFNG IL4 STAT1 TLR2 TLR3
30
Show member pathways
11.97 ADAR IFNA1 IFNAR2 IFNB1 IFNG IL2
31 11.93 IFNA1 IFNAR2 IFNB1 IFNG IL2 STAT1
32 11.92 DDX58 EIF2AK2 IFNA1 IFNAR2 IFNB1 STAT1
33 11.85 IFNG IL2 IL4 STAT1
34 11.83 CD209 IFNB1 IFNG IL2 SLAMF1
35
Show member pathways
11.81 CD40LG IFNG IL2 IL4
36 11.78 CD40LG FCGR2B IL4 SLAMF1 TLR2
37 11.77 IFNG IL2 IL4
38 11.69 IFNAR2 IFNG IL2
39
Show member pathways
11.66 CD40LG IFNG IL2
40
Show member pathways
11.64 IFNAR2 IFNG IL2
41 11.54 CD40LG IFNG TLR2
42 11.51 IFNG IL2 IL4
43 11.46 EIF2AK2 IFNB1 IFNG STAT1
44 11.4 CD40LG IFNG IL2 IL4
45 11.34 IFNB1 IFNG IL2 IL4
46 11.24 IFNG IL2 IL4
47
Show member pathways
11.08 ADAR DDX58 EIF2AK2 IFNAR2 STAT1

GO Terms for Measles

Cellular components related to Measles according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.86 CD40LG IFNA1 IFNAR2 IFNB1 IFNG IL2
2 extracellular region GO:0005576 9.85 CD209 CD40LG IFNA1 IFNAR2 IFNB1 IFNG
3 cell surface GO:0009986 9.5 CD209 CD40LG CD46 MSN SLAMF1 TLR2
4 external side of plasma membrane GO:0009897 9.02 CD209 CD40LG IFNG IL4 SLAMF1

Biological processes related to Measles according to GeneCards Suite gene sharing:

(show top 50) (show all 57)
id Name GO ID Score Top Affiliating Genes
1 positive regulation of protein phosphorylation GO:0001934 9.99 IFNG IL2 IL4 TLR3
2 positive regulation of NF-kappaB transcription factor activity GO:0051092 9.98 CD40LG EIF2AK2 TLR2 TLR3
3 viral process GO:0016032 9.97 CD209 CD46 DDX58 EIF2AK2 FCGR2B IFIH1
4 innate immune response GO:0045087 9.96 ADAR CD209 CD46 DDX58 EIF2AK2 IFIH1
5 viral entry into host cell GO:0046718 9.93 CD209 CD46 NECTIN4 SLAMF1
6 B cell differentiation GO:0030183 9.91 CD40LG IFNA1 IFNB1 IL4
7 adaptive immune response GO:0002250 9.91 CD209 CD46 IFNA1 IFNB1 IFNG IL2
8 positive regulation of inflammatory response GO:0050729 9.89 IL2 TLR2 TLR3
9 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.88 IFNG IL2 IL4
10 humoral immune response GO:0006959 9.87 IFNA1 IFNB1 IFNG
11 positive regulation of tumor necrosis factor production GO:0032760 9.87 IFNG TLR2 TLR3
12 positive regulation of interleukin-6 production GO:0032755 9.86 DDX58 TLR2 TLR3
13 defense response GO:0006952 9.86 IFNA1 IFNB1 TLR3
14 negative regulation of viral genome replication GO:0045071 9.86 ADAR EIF2AK2 IFNB1
15 B cell proliferation GO:0042100 9.85 CD40LG IFNA1 IFNB1
16 response to exogenous dsRNA GO:0043330 9.85 DDX58 IFNA1 IFNB1 TLR3
17 type I interferon signaling pathway GO:0060337 9.85 ADAR IFNA1 IFNAR2 IFNB1 STAT1
18 immune system process GO:0002376 9.85 ADAR CD209 CD46 DDX58 EIF2AK2 IFIH1
19 positive regulation of activated T cell proliferation GO:0042104 9.83 IL2 IL4 SLAMF1
20 positive regulation of interleukin-8 production GO:0032757 9.83 DDX58 TLR2 TLR3
21 regulation of type I interferon-mediated signaling pathway GO:0060338 9.83 IFNA1 IFNAR2 IFNB1 STAT1
22 positive regulation of T cell proliferation GO:0042102 9.83 CD40LG CD46 IFNG IL2 IL4
23 leukocyte cell-cell adhesion GO:0007159 9.81 CD209 CD40LG MSN
24 positive regulation of interferon-beta production GO:0032728 9.81 DDX58 IFIH1 TLR2 TLR3
25 positive regulation of peptidyl-serine phosphorylation of STAT protein GO:0033141 9.8 IFNA1 IFNB1 IFNG
26 positive regulation of interleukin-12 production GO:0032735 9.8 CD40LG IFNG TLR2 TLR3
27 positive regulation of chemokine production GO:0032722 9.79 EIF2AK2 TLR2 TLR3
28 positive regulation of interleukin-10 production GO:0032733 9.78 CD40LG CD46 IL4 TLR2
29 microglial cell activation GO:0001774 9.77 IL4 TLR2 TLR3
30 cellular response to interferon-beta GO:0035458 9.77 IFNB1 STAT1 TLR3
31 positive regulation of isotype switching to IgG isotypes GO:0048304 9.75 IFNG IL2 IL4
32 positive regulation of chemokine biosynthetic process GO:0045080 9.74 IFNG IL4 TLR3
33 response to interferon-alpha GO:0035455 9.73 ADAR EIF2AK2 IFNAR2
34 regulation of interferon-gamma-mediated signaling pathway GO:0060334 9.72 IFNG STAT1
35 I-kappaB phosphorylation GO:0007252 9.72 TLR2 TLR3
36 positive regulation of regulatory T cell differentiation GO:0045591 9.72 CD46 IL2
37 positive regulation of JNK cascade GO:0046330 9.71 SLAMF1 TLR3
38 response to interferon-beta GO:0035456 9.71 IFNAR2 STAT1
39 detection of virus GO:0009597 9.71 DDX58 IFIH1 TLR3
40 positive regulation of MHC class II biosynthetic process GO:0045348 9.7 IFNG IL4
41 cellular response to dsRNA GO:0071359 9.7 IFNB1 TLR3
42 negative regulation of T-helper 17 cell differentiation GO:2000320 9.68 IL2 IL4
43 positive regulation of toll-like receptor signaling pathway GO:0034123 9.67 TLR2 TLR3
44 interleukin-10 production GO:0032613 9.67 CD46 TLR2
45 cytoplasmic pattern recognition receptor signaling pathway in response to virus GO:0039528 9.65 DDX58 IFIH1
46 regulation of type III interferon production GO:0034344 9.64 DDX58 IFIH1
47 positive regulation of defense response to virus by host GO:0002230 9.63 DDX58 IL4
48 positive regulation of interferon-alpha production GO:0032727 9.58 DDX58 IFIH1
49 response to virus GO:0009615 9.56 ADAR DDX58 EIF2AK2 IFIH1 IFNAR2 IFNB1
50 negative regulation of macrophage activation GO:0043031 9.4 IL4

Molecular functions related to Measles according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 receptor activity GO:0004872 9.65 CD46 NECTIN4 SLAMF1 TLR2 TLR3
2 cytokine receptor binding GO:0005126 9.5 IFNA1 IFNB1 IL4
3 virus receptor activity GO:0001618 9.46 CD209 CD46 NECTIN4 SLAMF1
4 cytokine activity GO:0005125 9.43 CD40LG IFNA1 IFNB1 IFNG IL2 IL4
5 double-stranded RNA binding GO:0003725 9.02 DDX58 EIF2AK2 IFIH1 MSN TLR3

Sources for Measles

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....